Anti-Seizure Medication Use

    Basic Details
    Date Posted
    Wednesday, January 8, 2014
    Status
    Complete
    Medical Product
    carbamazepine
    ethosuxamide
    felbamate
    gabapentin
    lamotrigine
    levetiracetam
    oxcarbazepine
    phentermine HCl
    phentermine resin
    phenytoin
    phenytoin sodium
    phenytoin sodium extended
    pregabalin
    tiagabine HCL
    topiramate
    valproic acid
    zonisamide
    Description

    Summary table assessment of the use of seventeen anti-seizure drug products: topiramate, phentermine HCL, phentermine resin, carbamazepine, ethosuximide, felbamate, tiagabine HCL, levetiracetam, lamotrigine, pregabalin, gabapentin, phenytoin, phenytoin sodium, phenytoin sodium extended, oxcarbazepine, valproic acid,  and zonisamide. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table. Summary tables are precompiled stratified counts. Queries were executed in December 2012. This report includes data from 17 Data Partners.

    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    CDER
    Time Period
    2000-2011
    Study Type
    Summary Table
    Assessment Type
    Exploratory Analyses
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)